UBS Group
COCHW icon

UBS Group’s Envoy Medical Warrant COCHW Stock Holding History

UBS Group’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-482
Closed -$18 – 10583
2025
Q3 		$18 Buy
+482
New +$21 ﹤0.01% 10141
2024
Q3 		– Sell
-46
Closed -$2 – 9560
2024
Q2 		$2 Sell
46
-2,130
-98% -$233 ﹤0.01% 9419
2024
Q1 		$231 Sell
2,176
-1,939
-47% -$130 ﹤0.01% 8703
2023
Q4 		$82 Buy
+4,115
New +$111 ﹤0.01% 8949
2023
Q2 		– Sell
-600
Closed -$19 – 9008
2023
Q1 		$19 Buy
600
+193
+47% +$11 ﹤0.01% 9427
2022
Q4 		$16 Sell
407
-1,300
-76% -$62 ﹤0.01% 10565
2022
Q3 		$0 Hold
1,707
– – ﹤0.01% 10406
2022
Q2 		$0 Hold
1,707
– – ﹤0.01% 10383
2022
Q1 		$0 Hold
1,707
– – ﹤0.01% 10325
2021
Q4 		$1K Buy
+1,707
New +$1.25K ﹤0.01% 9960
2021
Q3 		– Sell
-2,101
Closed -$2K – 9599
2021
Q2 		$2K Buy
+2,101
New +$1.5K ﹤0.01% 8933

Other funds holding COCHW

OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

UBS Group's COCHW Position: Q4 2025 in Review

UBS Group sold out of Envoy Medical Warrant (COCHW) in Q4 2025, closing a stake of 482 shares — an estimated $18 sold.

UBS Group first reported a position in COCHW in Q2 2021 and held it in 11 quarters. The position peaked at $2K in Q2 2021. 35 funds tracked by Wall St. Rank hold COCHW as of Q4 2025.

  • UBS Group reported no remaining Envoy Medical Warrant position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 482 Envoy Medical Warrant shares in Q4 2025, an estimated $18.
  • UBS Group first reported a position in Envoy Medical Warrant in Q2 2021 and held it in 11 quarters.
  • UBS Group's Envoy Medical Warrant position peaked at $2K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.